
4DMedical
(ASX) 4DX
4DMedical Financials at a Glance
Market Cap
A$2.16B
Revenue (TTM)
A$10.19M
Net Income (TTM)
-A$199.13M
EPS (TTM)
-A$0.34
P/E Ratio
-10.82
Dividend
A$0.00
Beta (Volatility)
-0.26 (Low)
Dividend
A$0.00
Beta (Volatility)
-0.26 (Low)
Price
A$3.68
Volume
4,583,014
Open
A$3.66
Price
A$3.68
Volume
4,583,014
Open
A$3.66
Previous Close
A$3.68
Daily Range
A$3.60 - A$3.77
52-Week Range
A$0.23 - A$7.55
Estimated Earnings Date
Aug 27, 2026
Dividend
A$0.00
Beta (Volatility)
-0.26 (Low)
Price
A$3.68
Volume
4,583,014
Open
A$3.66
Previous Close
A$3.68
Daily Range
A$3.60 - A$3.77
52-Week Range
A$0.23 - A$7.55
Estimated Earnings Date
Aug 27, 2026
4DX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 4DMedical
Industry
Health Care Technology
Sector
Health CareEmployees
124
CEO
Andreas Fouras, PhD
Website
www.4dmedical.comHeadquarters
Carlton, VIC 3053, AU
4DX Financials
Key Financial Metrics (TTM)
Gross Margin
-4%
Operating Margin
-12%
Net Income Margin
-37%
Return on Equity
-1049%
Return on Capital
-39%
Return on Assets
-1%
Earnings Yield
-9.24%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
A$2.16B
Shares Outstanding
595.10M
Volume
4.58M
Avg. Volume
8.43M
Financials (TTM)
Gross Profit
A$5.39M
Operating Income
-A$47.50M
EBITDA
-A$45.82M
Operating Cash Flow
-A$34.48M
Capital Expenditure
-A$85.84K
Free Cash Flow
-A$34.56M
Cash & ST Invst.
A$6.88M
Total Debt
A$4.31M
4DMedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
A$2.85M
+259.9%
Gross Profit
-A$18.52M
-44.5%
Gross Margin
-6.49%
N/A
Market Cap
A$2.16B
N/A
Market Cap/Employee
A$14.90M
N/A
Employees
145
N/A
Net Income
-A$154.14M
-887.7%
EBITDA
-A$23.78M
-42.0%
Quarterly Fundamentals
Total Cash
A$56.76M
+18.6%
Total Debt
A$6.42M
-66.6%
Accounts Receivable
A$3.11M
-69.9%
Inventory
A$919.63K
-17.3%
Long Term Debt
A$5.27M
-71.6%
Short Term Debt
A$1.14M
-11.6%
Return on Assets
-1.14%
N/A
Return on Invested Capital
-38.89%
N/A
Free Cash Flow
-A$12.80M
+16.7%
Operating Cash Flow
-A$12.66M
+14.1%